Back

ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19

European Heart Journal

20 July 2020
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE

Contributors

Laura Lupi
Laura Lupi

Author

Marianna Adamo
Marianna Adamo

Author

Civil Hospital of Brescia Brescia , Italy

Riccardo M Inciardi
Riccardo M Inciardi

Author

Civil Hospital of Brescia Brescia , Italy

Marco Metra
Marco Metra

Author

IRCCS San Raffaele Scientific Institute Milan , Italy

You may be interested in
thumbnail
Congress Presentation
Systemic thromboembolism secondary to acute myocardial infarction in a patient with coronavirus disease.
18 March 2022
thumbnail
Congress Presentation
Endothelial biomarkers (Von Willebrand Factor, BDCA3, Urokinase) as predictors of mortality in COVID-19 patients.
22 May 2023
thumbnail
Congress Presentation
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
26 August 2022
thumbnail
Webinar
Cardiovascular involvement in COVID-19 patients: multimodality imaging for diagnosis, risk stratification and management
10 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources